Celldex Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 1.43, indicating more challenging environment then in the fourth quarter 2025, but still, it is a far cry from any concerns. Celldex Therapeutics Inc 's Accounts Receivable average collection period in the Mar 31 2026 quarter, has increased to 255 days, from 192 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector Celldex Therapeutics inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Celldex Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CLDX Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	-78.38 %	187.86 %	-89.44 %	-94.13 %	-60.16 %
Y / Y Revenue Change	-97.84 %	-89.79 %	-	-70.78 %	345.51 %
Receivable Turnover Ratio (TTM)	1.43	1.9	5.35	8.56	7.29
CLDX's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	256	192	68	43	50
Seq. Receivable Change	-88.59 %	2138.89 %	0 %	-91.54 %	52 %
Seq. Revenue Change	-87.5 %	-	-	5.04 %	-40.85 %

Receivable Turnover Company Ranking
Within:	No.
In Vitro & In Vivo Diagnostic Substances Industry	#
Healthcare Sector	#
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0

CLDX Company Profile • Back to CLDX Efficiency Comparisons • Compare CLDX Receivables Turnover Ratio to its Competitors

Financial Statements
Celldex Therapeutics Inc 's Accounts Receivable	$ 0 Millions	Visit CLDX's Balance sheet
Celldex Therapeutics Inc 's Sales TTM	$ 1 Millions	Visit CLDX's Income Statement
Sources of CLDX's Revenues		Visit CLDX's Sales by Geography

Other Accounts Receivable Turnover Ratios
In Vitro & In Vivo Diagnostic Substances Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CLDX's Receivable Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CLDX's Growth Rates	CLDX's Roa	CLDX's Inventory Turnover Ratio	CLDX's Dividend Comparisons
CLDX's Profitability Ratios	CLDX's Roi	CLDX's Asset Turnover Ratio	CLDX's Dividend Growth
CLDX's Valuation Ratios	CLDX's Roe	CLDX's Financial Strength Ratios	CLDX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
International Stem Cell Corporation	10.23	$ 9.286 Millions	$ 0.908 Millions
Pavmed Inc	10.19	$ 0.107 Millions	$ 0.011 Millions
Viemed Healthcare Inc	10.16	$ 286.565 Millions	$ 28.217 Millions
Addus Homecare Corp	10.14	$ 1,447.070 Millions	$ 142.667 Millions
Utah Medical Products Inc	10.13	$ 36.745 Millions	$ 3.629 Millions
Petvivo Holdings Inc	10.10	$ 0.821 Millions	$ 0.081 Millions
Irhythm Holdings Inc	10.00	$ 787.387 Millions	$ 78.720 Millions
C4 Therapeutics Inc	9.97	$ 34.861 Millions	$ 3.496 Millions
Biodesix Inc	9.94	$ 96.096 Millions	$ 9.665 Millions
Radnet Inc	9.87	$ 2,144.442 Millions	$ 217.223 Millions
Lensar Inc	9.87	$ 57.704 Millions	$ 5.847 Millions
X4 Pharmaceuticals Inc	9.69	$ 9.014 Millions	$ 0.931 Millions
Septerna Inc	9.64	$ 72.255 Millions	$ 7.499 Millions
Encompass Health Corporation	9.63	$ 6,066.400 Millions	$ 629.625 Millions
Biolife Solutions Inc	9.51	$ 99.673 Millions	$ 10.478 Millions
Biofrontera Inc	9.49	$ 42.983 Millions	$ 4.530 Millions
United Therapeutics Corporation	9.47	$ 3,169.800 Millions	$ 334.800 Millions
Tandem Diabetes Care Inc	9.34	$ 1,023.420 Millions	$ 109.550 Millions
Sunshine Biopharma Inc	9.33	$ 35.493 Millions	$ 3.804 Millions
The Oncology Institute Inc	9.30	$ 545.764 Millions	$ 58.671 Millions
The Pennant Group Inc	9.28	$ 1,023.227 Millions	$ 110.305 Millions
Volitionrx Limited	9.23	$ 2.466 Millions	$ 0.267 Millions
Lucid Diagnostics Inc	9.11	$ 5.134 Millions	$ 0.564 Millions
Soleno Therapeutics Inc	9.09	$ 285.008 Millions	$ 31.369 Millions
Zomedica Corp	9.07	$ 34.660 Millions	$ 3.820 Millions
Dariohealth Corp	9.03	$ 20.983 Millions	$ 2.324 Millions
Harmony Biosciences Holdings inc	9.02	$ 899.247 Millions	$ 99.660 Millions
Tactile Systems Technology Inc	9.01	$ 343.414 Millions	$ 38.110 Millions
Ardent Health Inc	8.99	$ 6,428.975 Millions	$ 715.036 Millions
Sanuwave Health Inc	8.91	$ 44.328 Millions	$ 4.973 Millions

Date modified: 2026-08-29T17:16:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.